共 50 条
Next generation sequencing in cytology
被引:44
|作者:
Pisapia, Pasquale
[1
]
Pepe, Francesco
[1
]
Sgariglia, Roberta
[1
]
Nacchio, Mariantonia
[1
]
Russo, Gianluca
[1
]
Conticelli, Floriana
[1
]
Girolami, Ilaria
[2
]
Eccher, Albino
[3
,4
]
Bellevicine, Claudio
[1
]
Vigliar, Elena
[1
]
Malapelle, Umberto
[1
]
Troncone, Giancarlo
[1
]
机构:
[1] Univ Naples Federico II, Dept Publ Hlth, Via Sergio Pansini 5, I-80131 Naples, Italy
[2] Cent Hosp Bolzano, Div Pathol, Bolzano, Italy
[3] Univ Verona, Dept Pathol & Diagnost, Verona, Italy
[4] Hosp Trust Verona, Verona, Italy
关键词:
biomarkers;
cytopathology;
FNA;
molecular cytopathology;
next generation sequencing;
FINE-NEEDLE-ASPIRATION;
MOLECULAR TESTING GUIDELINE;
WORLDWIDE RING TRIAL;
LUNG-CANCER PATIENTS;
DNA YIELD;
SPECIMENS;
CYTOPATHOLOGY;
DIAGNOSIS;
SAMPLES;
BIOPSY;
D O I:
10.1111/cyt.12974
中图分类号:
Q2 [细胞生物学];
学科分类号:
071009 ;
090102 ;
摘要:
The application of next generation sequencing (NGS) technology to cytological samples has significantly modified molecular cytopathology practice. Cytological samples represent a valid source of high-quality DNA for NGS analysis, especially for predicting patients' response to targeted treatments and for refining the risk of malignancy in indeterminate cytological diagnoses. However, several pre-analytical factors may influence the reliability of NGS clinical analysis. Here, we briefly review the challenges of NGS in cytology practice, focusing on those pre-analytical factors that may negatively affect NGS success rates and routine diagnostic applications. Finally, we address the future directions of the field.
引用
收藏
页码:588 / 595
页数:8
相关论文